31.01.2013 - EU antitrust regulators stepped up their fight against companies blocking the market entry of cheaper generic medicines, with charges against Johnson & Johnson and Novartis over a...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)